 Connection
John Thompson to Humans
This is a "connection" page, showing publications John Thompson has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.536 |
|
|
|
-
Platt JP, Radcliffe EM, Klimczak SL, Gliske SV, Kovach CK, Maroni D, Abosch A, Thompson JA. Multi-day recordings and adaptive stimulation protocols for in-home collection of deep brain stimulation intracranial recordings. J Neurosci Methods. 2025 Jun; 418:110442.
Score: 0.025
-
Satzer D, Kaye LC, Ojemann SG, Kramer DR, Thompson JA. Aperiodic activity as a biomarker of seizures and neuromodulation. Brain Stimul. 2025 May-Jun; 18(3):738-744.
Score: 0.025
-
Ryan MV, Satzer D, Ojemann SG, Kramer DR, Thompson JA. Neurophysiologic Characteristics of the Anterior Nucleus of the Thalamus during Deep Brain Stimulation Surgery for Epilepsy. Stereotact Funct Neurosurg. 2024; 102(5):293-307.
Score: 0.024
-
Bayman E, Chee K, Mendlen M, Denman DJ, Tien RN, Ojemann S, Kramer DR, Thompson JA. Subthalamic nucleus synchronization between beta band local field potential and single-unit activity in Parkinson's disease. Physiol Rep. 2024 May; 12(9):e16001.
Score: 0.023
-
West LC, Summers M, Tang S, Hirt L, Halpern CH, Maroni D, Das R, Gliske SV, Abosch A, Kushida CA, Thompson JA. Evaluation of consensus sleep stage scoring of dysregulated sleep in Parkinson's disease. Sleep Med. 2023 07; 107:236-242.
Score: 0.022
-
Radcliffe EM, Baumgartner AJ, Kern DS, Al Borno M, Ojemann S, Kramer DR, Thompson JA. Oscillatory beta dynamics inform biomarker-driven treatment optimization for Parkinson's disease. J Neurophysiol. 2023 06 01; 129(6):1492-1504.
Score: 0.022
-
Lewis S, Radcliffe E, Ojemann S, Kramer DR, Hirt L, Case M, Holt-Becker AB, Raike R, Kern DS, Thompson JA. Pilot Study to Investigate the Use of In-Clinic Sensing to Identify Optimal Stimulation Parameters for Deep Brain Stimulation Therapy in Parkinson's Disease. Neuromodulation. 2024 Apr; 27(3):509-519.
Score: 0.022
-
McDermott D, Darwin ML, Fetrow K, Coulter I, Biesecker K, Thompson JA. Cannabis use patterns in drug-resistant and pharmacoresponsive epilepsy: Single tertiary referral center survey investigation. PLoS One. 2023; 18(1):e0281040.
Score: 0.021
-
Tekriwal A, Baker S, Christensen E, Petersen-Jones H, Tien RN, Ojemann SG, Kern DS, Kramer DR, Felsen G, Thompson JA. Quantifying neuro-motor correlations during awake deep brain stimulation surgery using markerless tracking. Sci Rep. 2022 10 27; 12(1):18120.
Score: 0.021
-
Baker S, Tekriwal A, Felsen G, Christensen E, Hirt L, Ojemann SG, Kramer DR, Kern DS, Thompson JA. Automatic extraction of upper-limb kinematic activity using deep learning-based markerless tracking during deep brain stimulation implantation for Parkinson's disease: A proof of concept study. PLoS One. 2022; 17(10):e0275490.
Score: 0.021
-
Kern D, Korsmo M, Baumgartner AJ, Kramer D, Ojemann S, Case M, Holt-Becker AB, Raike R, Thompson JA. Methylphenidate effects on a clinically informative oscillatory signal within the subthalamic nucleus in Parkinson's disease during deep brain stimulation programming. Brain Stimul. 2022 May-Jun; 15(3):747-749.
Score: 0.020
-
Hirt L, Kern DS, Ojemann S, Grassia F, Kramer D, Thompson JA. Use of Three-Dimensional Printed Brain Models During Deep Brain Stimulation Surgery Consultation for Patient Health Literacy: A Randomized Controlled Investigation. World Neurosurg. 2022 06; 162:e526-e533.
Score: 0.020
-
Tekriwal A, Felsen G, Ojemann SG, Abosch A, Thompson JA. Motor context modulates substantia nigra pars reticulata spike activity in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2022 04; 93(4):386-394.
Score: 0.020
-
Kern DS, Uy D, Rhoades R, Ojemann S, Abosch A, Thompson JA. Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2020 09; 91(9):928-937.
Score: 0.018
-
D'Souza S, Ormond DR, Costabile J, Thompson JA. Fiber-tract localized diffusion coefficients highlight patterns of white matter disruption induced by proximity to glioma. PLoS One. 2019; 14(11):e0225323.
Score: 0.017
-
Winter M, Costabile JD, Abosch A, Thompson JA. Method for localizing intraoperative recordings from deep brain stimulation surgery using post-operative structural MRI. Neuroimage Clin. 2018; 20:1123-1128.
Score: 0.016
-
Tekriwal A, Felsen G, Thompson JA. Modular auditory decision-making behavioral task designed for intraoperative use in humans. J Neurosci Methods. 2018 07 01; 304:162-167.
Score: 0.015
-
Thompson JA, Tekriwal A, Felsen G, Ozturk M, Telkes I, Wu J, Ince NF, Abosch A. Sleep patterns in Parkinson's disease: direct recordings from the subthalamic nucleus. J Neurol Neurosurg Psychiatry. 2018 01; 89(1):95-104.
Score: 0.015
-
Thompson JA, Yin D, Ojemann SG, Abosch A. Use of the Putamen as a Surrogate Anatomical Marker for the Internal Segment of the Globus Pallidus in Deep Brain Stimulation Surgery. Stereotact Funct Neurosurg. 2017; 95(4):229-235.
Score: 0.015
-
Kolb R, Abosch A, Felsen G, Thompson JA. Use of intraoperative local field potential spectral analysis to differentiate basal ganglia structures in Parkinson's disease patients. Physiol Rep. 2017 Jun; 5(12).
Score: 0.014
-
Thompson JA, Lanctin D, Ince NF, Abosch A. Clinical implications of local field potentials for understanding and treating movement disorders. Stereotact Funct Neurosurg. 2014; 92(4):251-63.
Score: 0.012
-
Shearn CT, Fritz KS, Meier BW, Kirichenko OV, Thompson JA. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Chem Res Toxicol. 2008 Aug; 21(8):1631-41.
Score: 0.008
-
Das R, Gliske SV, Maroni D, Situ-Kcomt M, West LC, Summers MO, Tang S, Vaswani PA, Halpern CH, Thompson JA, Kushida CA, Abosch A. Sleep spindle variation in patients with Parkinson's disease on first nights of sub-optimal deep brain stimulation. Clin Neurophysiol. 2025 Feb; 170:91-97.
Score: 0.006
-
Martinez-Perez R, Casanova-Martinez D, Thompson JA, Hirt L, Kortz M, Labib MAM, Razmara A, Youssef AS. Circumferential exposure of the cavernous sinus and parasellar region through a combined open and endoscopic endonasal transcavernous approach, a morphometric study. Acta Neurochir (Wien). 2024 Oct 09; 166(1):399.
Score: 0.006
-
Das R, Gliske SV, West LC, Summers MO, Tang S, Hirt L, Maroni D, Halpern CH, Thompson JA, Kushida CA, Abosch A. Sleep macro-architecture in patients with Parkinson's disease does not change during the first night of neurostimulation in a pilot study. J Clin Sleep Med. 2024 Sep 01; 20(9):1489-1496.
Score: 0.006
-
Freeman LM, Ung TH, Thompson JA, Ovard O, Olson M, Hirt L, Hosokawa P, Thaker A, Youssef AS. Refining the predictive value of preoperative apparent diffusion coefficient (ADC) by whole-tumor analysis for facial nerve outcomes in vestibular schwannomas. Acta Neurochir (Wien). 2024 Apr 05; 166(1):168.
Score: 0.006
-
Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA. Short-Term Cannabidiol with ?-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial. Mov Disord. 2024 May; 39(5):863-875.
Score: 0.006
-
Chee K, Hirt L, Mendlen M, Machnik J, Razmara A, Bayman E, Thompson JA, Kramer DR. Brain Shift during Staged Deep Brain Stimulation for Movement Disorders. Stereotact Funct Neurosurg. 2024; 102(2):83-92.
Score: 0.006
-
Ung TH, Freeman L, Hirt L, Kortz M, Belanger K, Baird-Daniel E, Hosokawa P, Thaker A, Thompson JA, Youssef AS. Surgical outcomes in large vestibular schwannomas: should cerebellopontine edema be considered in the grading systems? Acta Neurochir (Wien). 2023 07; 165(7):1749-1755.
Score: 0.005
-
Baumgartner AJ, Thompson JA, Kern DS, Ojemann SG. Novel targets in deep brain stimulation for movement disorders. Neurosurg Rev. 2022 Aug; 45(4):2593-2613.
Score: 0.005
-
Hirt L, Grassia F, Feuerstein J, Thompson JA, Ojemann S, Kern DS. Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus in Writer's Cramp: A Case Report. Tremor Other Hyperkinet Mov (N Y). 2021; 11:46.
Score: 0.005
-
Murcia D, D'Souza S, Abozeid M, Thompson JA, Djoyum TD, Ormond DR. Investigation of Asleep versus Awake Motor Mapping in Resective Brain Surgery. World Neurosurg. 2022 01; 157:e129-e136.
Score: 0.005
-
Ung TH, Kahn L, Hirt L, Chatain G, Humes E, David-Gerecht P, Drees C, Thompson JA, Ojemann S, Abosch A. Using a Robotic-Assisted Approach for Stereotactic Laser Ablation Corpus Callosotomy: A Technical Report. Stereotact Funct Neurosurg. 2022; 100(1):61-66.
Score: 0.005
-
Fringuello A, Tatman PD, Wroblewski T, Thompson JA, Yu X, Lillehei KO, Kowalski RG, Graner MW. Cytokine-Laden Extracellular Vesicles Predict Patient Prognosis after Cerebrovascular Accident. Int J Mol Sci. 2021 Jul 22; 22(15).
Score: 0.005
-
Thaker AA, Reddy KM, Thompson JA, Gerecht PD, Brown MS, Abosch A, Ojemann SG, Kern DS. Coronal Gradient Echo MRI to Visualize the Zona Incerta for Deep Brain Stimulation Targeting in Parkinson's Disease. Stereotact Funct Neurosurg. 2021; 99(5):443-450.
Score: 0.005
-
Kern DS, Fasano A, Thompson JA, Abosch A, Ojemann S, Munhoz RP. Constant Current versus Constant Voltage: Clinical Evidence Supporting a Fundamental Difference in the Modalities. Stereotact Funct Neurosurg. 2021; 99(2):171-175.
Score: 0.005
-
Youssef AS, Arnone GD, Farell NF, Thompson JA, Ramakrishnan VR, Gubbels S, Cohen-Gadol AA, Cass S, Labib MA. The Combined Endoscopic Endonasal Far Medial and Open Postauricular Transtemporal Approaches As a Lesser Invasive Approach to the Jugular Foramen: Anatomic Morphometric Study With Case Illustration. Oper Neurosurg (Hagerstown). 2020 09 15; 19(4):471-479.
Score: 0.005
-
Gault JM, Thompson JA, Maharajh K, Hosokawa P, Stevens KE, Olincy A, Liedtke EI, Ojemann A, Ojemann S, Abosch A. Striatal and Thalamic Auditory Response During Deep Brain Stimulation for Essential Tremor: Implications for Psychosis. Neuromodulation. 2020 Jun; 23(4):478-488.
Score: 0.004
-
Pang Y, Christenson J, Jiang F, Lei T, Rhoades R, Kern D, Thompson JA, Liu C. Automatic detection and quantification of hand movements toward development of an objective assessment of tremor and bradykinesia in Parkinson's disease. J Neurosci Methods. 2020 03 01; 333:108576.
Score: 0.004
-
Kern DS, Picillo M, Thompson JA, Sammartino F, di Biase L, Munhoz RP, Fasano A. Interleaving Stimulation in Parkinson's Disease, Tremor, and Dystonia. Stereotact Funct Neurosurg. 2018; 96(6):379-391.
Score: 0.004
-
Christensen E, Abosch A, Thompson JA, Zylberberg J. Inferring sleep stage from local field potentials recorded in the subthalamic nucleus of Parkinson's patients. J Sleep Res. 2019 08; 28(4):e12806.
Score: 0.004
-
Vasquez CA, Thompson JA, Youssef AS. The Tentorial Bridge to Deep Skull Base Exposure: Anatomic Morphometric Study. World Neurosurg. 2018 Jun; 114:e588-e596.
Score: 0.004
-
Gault JM, Davis R, Cascella NG, Saks ER, Corripio-Collado I, Anderson WS, Olincy A, Thompson JA, Pomarol-Clotet E, Sawa A, Daskalakis ZJ, Lipsman N, Abosch A. Approaches to neuromodulation for schizophrenia. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):777-787.
Score: 0.004
-
Brown MG, Drees C, Nagae LM, Thompson JA, Ojemann S, Abosch A. Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy. J Neurol Neurosurg Psychiatry. 2018 Apr; 89(4):425-433.
Score: 0.004
-
Yin D, Thompson JA, Drees C, Ojemann SG, Nagae L, Pelak VS, Abosch A. Optic Radiation Tractography and Visual Field Deficits in Laser Interstitial Thermal Therapy for Amygdalohippocampectomy in Patients with Mesial Temporal Lobe Epilepsy. Stereotact Funct Neurosurg. 2017; 95(2):107-113.
Score: 0.004
-
Tekriwal A, Kern DS, Tsai J, Ince NF, Wu J, Thompson JA, Abosch A. REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease. J Neurol Neurosurg Psychiatry. 2017 05; 88(5):445-451.
Score: 0.004
-
Tyagi A, Raina K, Shrestha SP, Miller B, Thompson JA, Wempe MF, Agarwal R, Agarwal C. Procyanidin B2 3,3(?)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-?B, Stat3, and AP1 transcription factors. Nutr Cancer. 2014; 66(4):736-46.
Score: 0.003
-
Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma. Invest New Drugs. 2006 Jan; 24(1):89-94.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|